Platelet activation induced by human antibodies to interleukin-8

Blood. 2003 Feb 15;101(4):1419-21. doi: 10.1182/blood-2002-02-0620. Epub 2002 Oct 10.

Abstract

Some cases of heparin-induced thrombocytopenia (HIT) have been reported to be associated with antibodies against interleukin-8 (IL-8), a chemokine related to platelet factor 4. We found that sera from 5 HIT patients containing immunoglobulin G (IgG) or IgM antibodies to IL-8, as evidenced using surface plasmon resonance spectroscopy, were able to trigger IL-8-dependent activation of washed platelets, leading to procoagulant activity. This activation occurred at IL-8 concentrations achievable in vivo and was facilitated by heparin (0.1 U/mL). Activation was also induced by affinity-purified anti-IL-8 IgG and involved FcgammaRIIa. In the 2 patients who could be followed up, antibodies were no longer detectable 4 months after heparin withdrawal. One additional patient with paraneoplastic recurrent thrombosis without thrombocytopenia was found to have platelet-activating anti-IL-8 IgM, but in this case heparin was inhibitory. This is another example of potentially pathogenic platelet activation by antibodies.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies / blood
  • Antibodies / pharmacology*
  • Antigens, CD / physiology
  • Heparin / adverse effects
  • Heparin / pharmacology
  • Humans
  • Immunoglobulin G / pharmacology
  • Immunoglobulin M / pharmacology
  • Interleukin-8 / immunology*
  • Interleukin-8 / physiology*
  • Platelet Activation / drug effects*
  • Platelet Factor 4 / immunology
  • Receptors, IgG / physiology
  • Thrombocytopenia / chemically induced
  • Thrombocytopenia / immunology

Substances

  • Antibodies
  • Antigens, CD
  • Fc gamma receptor IIA
  • Immunoglobulin G
  • Immunoglobulin M
  • Interleukin-8
  • Receptors, IgG
  • Platelet Factor 4
  • Heparin